Large publicly listed hospital operators in the U.S. include HCA Healthcare, Tenet Healthcare Corp. and Community Health Systems.
Lost revenue from clinical studies can directly impact staffing and operations as sites are usually paid per visit, according to Nariman Nasser, an executive at Continuum Clinical, an industry consultant that works with trial sites.
ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
Large hospitals and academic centers also stand to lose fees that cover costs for things like building space, maintenance and operating costs, Nasser said in an email.
Last week, U.S.-based Iveric Bio Inc. delayed enrollment in a trial of its eye disease drug, two days after Provention Bio paused a study of a diabetes drug but allowed trial patients to complete their treatment course.